289 related articles for article (PubMed ID: 24625674)
1. Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction.
Teh BW; Azzato FA; Lingaratnam SM; Thursky KA; Slavin MA; Worth LJ
Med Mycol; 2014 May; 52(4):427-32. PubMed ID: 24625674
[TBL] [Abstract][Full Text] [Related]
2. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
[TBL] [Abstract][Full Text] [Related]
3. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.
Montesinos I; Brancart F; Schepers K; Jacobs F; Denis O; Delforge ML
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):143-7. PubMed ID: 25801778
[TBL] [Abstract][Full Text] [Related]
5. Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.
Fillaux J; Berry A
Methods Mol Biol; 2013; 943():159-70. PubMed ID: 23104289
[TBL] [Abstract][Full Text] [Related]
6. Molecular Diagnosis of
Goterris L; Mancebo Fernández MA; Aguilar-Company J; Falcó V; Ruiz-Camps I; Martín-Gómez MT
J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578265
[No Abstract] [Full Text] [Related]
7. Clinical significance of positive
Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
[TBL] [Abstract][Full Text] [Related]
8. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.
Mühlethaler K; Bögli-Stuber K; Wasmer S; von Garnier C; Dumont P; Rauch A; Mühlemann K; Garzoni C
Eur Respir J; 2012 Apr; 39(4):971-8. PubMed ID: 21920890
[TBL] [Abstract][Full Text] [Related]
9. Use of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: A single-center prospective study.
Desoubeaux G; Franck-Martel C; Caille A; Drillaud N; Lestrade Carluer de Kyvon MA; Bailly É; Chandenier J
Med Mycol; 2017 Apr; 55(3):295-301. PubMed ID: 27562860
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.
Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC
J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.
Botterel F; Cabaret O; Foulet F; Cordonnier C; Costa JM; Bretagne S
J Clin Microbiol; 2012 Feb; 50(2):227-31. PubMed ID: 22162560
[TBL] [Abstract][Full Text] [Related]
12. Two pediatric cases of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction of gastric lavage.
Takei H; Ishiwada N; Hishiki H; Takeshita K; Naito S; Endo M; Shimojo N
J Infect Chemother; 2019 Jun; 25(6):477-479. PubMed ID: 30797688
[TBL] [Abstract][Full Text] [Related]
13. Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India.
Chawla K; Martena S; Gurung B; Mukhopadhyay C; Varghese GK; Bairy I
Indian J Pathol Microbiol; 2011; 54(2):326-9. PubMed ID: 21623083
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
BMC Infect Dis; 2021 Jul; 21(1):659. PubMed ID: 34233631
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
[TBL] [Abstract][Full Text] [Related]
19. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]